第四届儿童机械循环支持机构间注册登记(Pedimacs)报告
Pedimacs数据库2012年9月19日至2019年12月31日期间44家医院为856例19岁以下患者植入1031台心室辅助装置(VAD)。诊断以心肌病(58%)、先天性心脏病(25%)、心肌炎(10%)为主,6个月积极结局达82%。植入式连续流(IC)泵6个月积极结局92%,高于搏动式(PP)81%和体外连续流(PC)68%,总体脑血管意外发生率为11%。
要点
- 儿童VAD以IC泵最常见,6个月积极结局92%优于PP(81%)和PC(68%)。
- PC和PP泵多用于病情更重的患者,其Intermacs 1级比例和插管比例更高。
- 儿童VAD总体脑血管意外发生率已降至11%,但PC和PP仍高于IC。
核心结论
- IC VAD是儿童中最常用的VAD类型, compared with PP和PC装置结局更优,但PP和PC装置限于支持病情最复杂的患者。
- 儿童VAD的脑血管意外发生率已显著下降,目前总体为11%。
- 尽管常归因于年龄、体型或装置类型,死亡和不良事件负担多与VAD植入时患者整体状态相关。
研究设计与样本
- Pedimacs为美国国立卫生研究院资助的数据库,2012年9月19日至2019年12月31日期间44家医院为856例19岁以下患者植入1031台装置。
主要发现
- 总体诊断:心肌病497例(58%)、先天性心脏病216例(25%)、心肌炎85例(10%)、其他58例(7%)。
- 6个月积极结局(带装置存活或桥接移植和恢复)总体为82%。
- IC泵队列(n=365)年龄13.2±3.9岁,Intermacs 1级18%,插管23%,CHD 16%;PC泵队列(n=212)年龄3.6±4.9岁,Intermacs 1级46%,插管81%,CHD 42%;PP泵队列(n=230)年龄2.7±3.5岁,Intermacs 1级31%,插管76%,CHD 26%。
- 6个月积极结局按装置类型:IC 92%、PC 68%、PP 81%。
- 脑血管意外发生率:IC 7%、PC 14%、PP 15%,总体11%。
临床怎么用
- 儿童VAD选择需综合评估患者植入时整体状态,IC泵结局优于PC和PP但后者用于更危重患者。
- 应关注儿童VAD脑血管意外风险,尤其PC和PP装置发生率较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs), originally a National Institutes of Health-sponsored U.S. database, provides a platform to understand the population of children supported with ventricular assist devices (VADs) during this time of increasing numbers, new devices, expanding indications, and improved outcomes. METHODS: Between September 19, 2012, and December 31, 2019, 44 hospitals implanted 1031 devices in 856 patients under 19 years of age. RESULTS: Overall, diagnosis was cardiomyopathy in 497 (58%) patients, congenital heart disease (CHD) in 216 (25%), myocarditis in 85 (10%), and other in 58 (7%). Positive outcome (alive on device or bridge to transplantation and recovery) occurred in 82% at 6 months. The patient cohort for implantable continuous (IC) pumps (n = 365) (age 13.2 ± 3.9 years, 18% Interagency Registry for Mechanically Assisted Circulatory Support [Intermacs] profile 1, 23% intubated at implantation, 16% with CHD) was significantly different from the paracorporeal continuous (PC) pump cohort (n = 212) (age 3.6 ± 4.9 years, 46% Intermacs profile 1, 81% intubated, 42% CHD) and the paracorporeal pulsatile (PP) pump cohort (n = 230) (age 2.7 ± 3.5 years, 31% Intermacs profile 1, 76% intubated, 26% CHD). Consistent with their cohort composition, positive outcomes at 6 months based on device type were the following: IC, 92%; PC, 68%; and PP, 81%. The incidence of cerebrovascular accidents in the IC, PC, and PP cohorts was 7%, 14%, and 15%, respectively. CONCLUSIONS: IC VADs, the most common VAD type placed in children, are associated with improved outcomes compared with PP and PC devices, though PP and PC devices are limited to supporting our most challenging patients. Noteworthy, the incidence of cerebrovascular accidents for pediatric VADs has significantly decreased and is now 11% overall. This report demonstrates again that although often attributed to age, size, or device type, much of the burden in mortality and adverse events is correlated to the patient's overall state at VAD implantation.
引用
- Morales DLS, Adachi I, Peng DM, et al. Fourth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report. Ann Thorac Surg. 2020. PMID: 33039359. doi:10.1016/j.athoracsur.2020.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。